Developmental pharmacokinetics of psychotropic drugs: olanzapine
Phase of Trial: Phase II
Latest Information Update: 08 Dec 2015
At a glance
- Drugs Olanzapine (Primary)
- Indications Bipolar disorders; Psychotic disorders
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Acronyms DSIR-CT-M
- 27 Jan 2014 Status changed from active, no longer recruiting to discontinued as per ClinicalTrials.gov record.
- 28 Oct 2006 New trial record.